Article
An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice
2019-07-08
Abstract excerpt
<h4>ABSTRACT</h4> Recombinant adeno-associated viral (AAV) vectors are frequently used to deliver nucleic acids for in vivo applications and are currently the leading platform for therapeutic gene delivery in gene therapy clinical trials. Presently, there is a need for improved AAV vectors with optimized transduction efficiency in target tissues. In these studies, an engineered albumin-binding consensus domain (A...
Topics
Open a Topic to create a Post that cites this publication.
- CAR-T cell therapy research
- CRISPR and Genetic Engineering
- Herpesvirus Infections and Treatments
- RNA Interference and Gene Delivery
- Viral gastroenteritis research and epidemiology
- Viral Infections and Immunology Research
- Viral Infectious Diseases and Gene Expression in Insects
- Virus-based gene therapy research
Identifiers and source
- Literature Corpus work
- 8e37b823-9346-5905-9fef-645927ba3783
- DOI
- 10.1101/694513
